Velloza, Jennifer http://orcid.org/0000-0001-7242-7415
,
Heffron, Renee
Amico, K. Rivet
Rowhani-Rahbar, Ali
Hughes, James P.
Li, Maoji
Dye, Bonnie J.
Celum, Connie
Bekker, Linda-Gail
Grant, Robert M.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1-AI068619, UM1-AI068617, UM1-AI068613, R01 AI118575, UM1AI069418)
National Institute of Mental Health (F31 MH113420)
Article History
First Online: 18 January 2020
Compliance with ethical standards
:
: RMG has been a site investigator for clinical trials funded by GlaxoSmithKline (GSK; managed by ViiV Healthcare) and Gilead Sciences to the Gladstone Institutes and the San Francisco AIDS Foundation. KRA received an unrestricted educational grant to the University of Michigan from Gilead Sciences (2015–2017). All other authors report no potential conflicts of interest.
: Ethical approval was obtained by the Human Research Ethics Committee (HREC) in South Africa and the protocol was reviewed by the National Institutes of Health (NIH) Division of AIDS (DAIDS) prior to implementation. Participants provided written informed consent in their preferred language. The protocol was registered at ClinicalTrials.gov (identifier NCT01327651).
: All procedures performed were in accordance with the ethical standards of the Human Research Ethics Committee (HREC) in South Africa and the National Institutes of Health (NIH) Division of AIDS (DAIDS), national research ethics committees for the study site, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.